E Lonn, S Yusuf - Current Opinion in Lipidology, 2009 - pdfs.journals.lww.com In 2002,Yusuf [4 ] hypothesized that a combination of four drugs [aspirin, a b-blocker, a statin
and an angio- tensin-converting enzyme (ACE) inhibitor] could reduce cardiovascular events
by about 75% in secondary pre- vention (the idea was first raised by Richard Peto at a ...
KS Sakariassen, P Alberts, P Fontana, J Mann, H … - Future Cardiol., 2009 - Future Medicine The present review focuses on the roles of thromboxane A 2 (TxA 2 ) in arterial thrombosis,
atherogenesis, vascular stent-related ischemic events and renal proteinuria. Particular emphasis
is laid on therapeutic interventions targeting the TxA 2 (TP) receptors and TxA 2 synthase ( ... Related articles - All 4 versions
OP Almeida, K Jamrozik, DPGJ Hankey, L Flicker - mbf.com.au Osvaldo P. Almeida, MD, PhD, FRANZCP1,2,3 Helman Alfonso, MD, PhD1,2 Konrad
Jamrozik, MBBS, DPhil4 Graeme J. Hankey, MD, FRCP, FRACP5,6 Leon Flicker, MBBS,
PhD, FRACP1,6,7 ... 1 Western Australia Centre for Health & Ageing 2 School of ... View as HTML
SI Al-Azzam, F AlMahasneh, N Mhaidat, … - Journal of Clinical …, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles
Q Shi, PDMB Elamin, VM Montori - Am Diabetes Assoc Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Review and
Meta-Analysis Comparing Patients With and Without Diabetes ... Running Title: Aspirin for Primary
Prevention in Diabetes ... Andrew D Calvin, MD, MPH1 Niti R Aggarwal, MD1 ... Related articles
BBF DATE, U Assessment - medscape.com The USPSTF recommends the use of aspirin for women age 55 to 79 years when the potential
benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal
hemorrhage. Go to the Clinical Considerations section for discussion of benefits and ... Related articles - All 2 versions
N Murri - medscape.com Since the 1980s, the new drug pipeline has yielded several oral, non-aspirin, antiplatelet agents
(see Table 1 ), but only one, clopidogrel, has made significant headway as an aspirin
alternative. From humble beginnings, [6-8] clopidogrel has risen to achieve blockbuster ... Related articles - All 2 versions
[CITATION] Benefits and risks of aspirin in secondary and primary prevention of cardiovascular …
AI Med - Ann Intern Med, 2009 - Am Coll Physicians I report the use of aspirin and clonazepam into two patients with essential arterial
hypertension(EAH)(unpublished observations ). CASE 1: A 65-year-old man with history of EAH
and treated with captopril, however, since July 2000,he received aspirin (500 mg/d) and ...
